Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Research Article

Burden of Ischemic Heart Diseases among US States from 1990-2019

Author(s): Saeed Abughazaleh, Omar Obeidat*, Mohammad Tarawneh, Hashim Al-Ani, Ahmad Al Nawaiseh and Mohamed F. Ismail

Volume 22, Issue 6, 2024

Published on: 03 May, 2024

Page: [426 - 436] Pages: 11

DOI: 10.2174/0115701611305792240426120709

Price: $65

Abstract

Background: Ischemic Heart Disease (IHD) is a leading cause of global mortality, including in the United States. Understanding the burden of IHD in the United States is crucial for informed decision-making and targeted interventions aimed at reducing morbidity and mortality associated with this leading cause of death. This study aimed to understand the burden of IHD, identify gender disparities and risk factors, explore the relationship between socioeconomic growth and IHD, and analyze risk factor distribution across the states of the United States.

Methods: This study utilized data from the Global Burden of Diseases Study 2019, which provided comprehensive information on IHD from 1990 to 2019. Data related to IHD from these years were extracted using a query tool from the Institute for Health Metrics and Evaluation (IHME) website. The study assessed the relationship between IHD and socioeconomic development using the Socio-demographic Index (SDI) and measured the overall impact of IHD using Disability-adjusted Life Years (DALYs), considering premature death and disability. Additionally, the study analyzed the burden of IHD attributed to six main risk factors. Data analysis involved comparing prevalence, mortality, SDI, DALYs, attributable burden, and risk estimation among the states.

Results: Between 1990 and 2019, there was an improvement in socioeconomic development in all states. Age-standardized rates of disease burden for IHD decreased by 50% [ASDR 3278.3 to 1629.4 (95% UI: 1539.9-1712.3) per 100,000] with the most significant decline observed in Minnesota. Males had higher burden rates than females in all states, and the southeast region had the highest mortality rates. The prevalence of IHD showed a declining trend, with approximately 8.9 million cases (95% UI: 8.0 million to 9.8 million) in 2019, representing a 37.1% decrease in the Age-standardized Prevalence Rate (ASPR) from 1990. Metabolic risks were the leading contributors to the disease burden, accounting for 50% of cases, with Mississippi having the highest attributable risk. Arkansas had the highest attributable risk for high cholesterol and smoking. Conversely, Minnesota had the lowest burden of IHD among all the states.

Conclusion: This study highlights variations in the burden of IHD across US states and emphasizes the need for tailored prevention programs to address specific risk factors and gender differences. Understanding the trend in IHD may inform policymakers and healthcare professionals in effectively allocating resources to reduce the burden of IHD and improve national health outcomes.

Keywords: Ischemic heart disease, Global Burden of Diseases, socio-demographic index, disability-adjusted life years, gender disparities, risk factors, cardiovascular diseases, mortality rates, prevalence rates.

Graphical Abstract
[1]
Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2016 update. Circulation 2016; 133(4): e38-e360.
[http://dx.doi.org/10.1161/CIR.0000000000000350] [PMID: 26673558]
[2]
World Health Organization. Noncommunicable diseases. 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
[3]
Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 2017; 70(1): 1-25.
[http://dx.doi.org/10.1016/j.jacc.2017.04.052] [PMID: 28527533]
[4]
Prabhakaran D, Jeemon P, Sharma M, et al. The changing patterns of cardiovascular diseases and their risk factors in the states of India: The global burden of disease study 1990–2016. Lancet Glob Health 2018; 6(12): e1339-51.
[http://dx.doi.org/10.1016/S2214-109X(18)30407-8] [PMID: 30219317]
[5]
Moran AE, Forouzanfar MH, Roth GA, et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: The global burden of disease 2010 study. Circulation 2014; 129(14): 1483-92.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.113.004042] [PMID: 24573352]
[6]
Centers for Disease Control and Prevention. Men and heart disease. 2022. Available from: https://www.cdc.gov/heartdisease/men.htm#:~:text=How%20does%20heart%20disease%20affect,in%20every%204%20male%20deaths (Accessed on: April 23, 2023).
[7]
GBD 2019 Diseases and Injuries Collaborators (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the global burden of disease study 2019. Lancet 2020;  396(10258): 1204-22.
[http://dx.doi.org/10.1016/S0140-6736(20)30925-9]
[8]
UN. World population prospects 2019: Highlights. 2019. Available from: https://population.un.org/wpp/Publications/Files/WPP2019_10KeyFindings.pdf (Accessed on: March 12, 2020).
[9]
Jilani MH, Javed Z, Yahya T, et al. Social determinants of health and cardiovascular disease: Current state and future directions towards healthcare equity. Curr Atheroscler Rep 2021; 23(9): 55.
[http://dx.doi.org/10.1007/s11883-021-00949-w] [PMID: 34308497]
[10]
Pepine CJ. Ischemic heart disease in women: Facts and wishful thinking. J Am Coll Cardiol 2004; 43(10): 1727-30.
[http://dx.doi.org/10.1016/j.jacc.2004.04.012] [PMID: 15145090]
[11]
Virtanen M, Vahtera J, Singh-Manoux A, Elovainio M, Ferrie JE, Kivimäki M. Unfavorable and favorable changes in modifiable risk factors and incidence of coronary heart disease: The Whitehall II cohort study. Int J Cardiol 2018; 269: 7-12.
[http://dx.doi.org/10.1016/j.ijcard.2018.07.005] [PMID: 30005835]
[12]
Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJV. The current cost of angina pectoris to the National Health Service in the UK. Br Heart J 2003; 89(8): 848-53.
[http://dx.doi.org/10.1136/heart.89.8.848] [PMID: 12860855]
[13]
Birger M, Kaldjian AS, Roth GA, Moran AE, Dieleman JL, Bellows BK. Spending on cardiovascular disease and cardiovascular risk factors in the United States: 1996 to 2016. Circulation 2021; 144(4): 271-82.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.120.053216] [PMID: 33926203]
[14]
Barquera S, Tobías PA, Medina C, et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res 2015; 46(5): 328-38.
[http://dx.doi.org/10.1016/j.arcmed.2015.06.006] [PMID: 26135634]
[15]
Khan MAB, Hashim MJ, Mustafa H, et al. Global epidemiology of ischemic heart disease: Results from the global burden of disease study. Cureus 2020; 12(7): e9349.
[http://dx.doi.org/10.7759/cureus.9349] [PMID: 32742886]
[16]
Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk. J Am Coll Cardiol 2022; 80(25): 2361-71.
[http://dx.doi.org/10.1016/j.jacc.2022.11.005] [PMID: 36368511]
[17]
Institute for Health Metrics and Evaluation. Ischemic heart disease — Level 3 cause. 2020. Available from: https://www.healthdata.org/results/gbd_summaries/2019/ischemic-heart-disease-level-3-cause (Accessed on: 26 May 2023).
[18]
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 2018; 72(18): 2231-64.
[http://dx.doi.org/10.1016/j.jacc.2018.08.1038] [PMID: 30153967]
[19]
Razo C, Welgan CA, Johnson CO, et al. Effects of elevated systolic blood pressure on ischemic heart disease: A burden of proof study. Nat Med 2022; 28(10): 2056-65.
[http://dx.doi.org/10.1038/s41591-022-01974-1] [PMID: 36216934]
[20]
Zheng P, Afshin A, Biryukov S, et al. The burden of proof studies: Assessing the evidence of risk. Nat Med 2022; 28(10): 2038-44.
[http://dx.doi.org/10.1038/s41591-022-01973-2] [PMID: 36216935]
[21]
Murray CJL, Aravkin AY, Zheng P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1223-49.
[http://dx.doi.org/10.1016/S0140-6736(20)30752-2] [PMID: 33069327]
[22]
Szadvári I, Ostatníková D, Durdiaková BJ. Sex differences matter: Males and females are equal but not the same. Physiol Behav 2023; 259: 114038.
[http://dx.doi.org/10.1016/j.physbeh.2022.114038] [PMID: 36423797]
[23]
Oksuzyan A, Gumà J, Doblhammer G. Sex differences in health and survival. A Demographic Perspective on Gender, Family and Health in Europe. Springer 2018; pp. 65-100.
[24]
Martin SS, Aday AW, Almarzooq ZI, et al. 2024 heart disease and stroke statistics: A report of US and global data from the American heart association. Circulation 2024; 149(8): e347-913.
[http://dx.doi.org/10.1161/CIR.0000000000001209] [PMID: 38264914]
[25]
Schiller JS, Norris T. Division of Health Interview Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention. Early release of selected estimates from the 2022 National Health Interview Survey. 2022. Available from: https://cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease202304.pdf (Accessed on: October 10, 2023).
[26]
Chatmon BN. Males and mental health stigma. Am J Men Health 2020; 14(4)
[http://dx.doi.org/10.1177/1557988320949322] [PMID: 32812501]
[27]
Zhou Y, Zhu XP, Shi JJ, et al. Coronary heart disease and depression or anxiety: A bibliometric analysis. Front Psychol 2021; 12: 669000.
[http://dx.doi.org/10.3389/fpsyg.2021.669000] [PMID: 34149564]
[28]
McKenzie SK, Oliffe JL, Black A, Collings S. Men’s experiences of mental illness stigma across the lifespan: A scoping review. Am J Men Health 2022; 16(1)
[http://dx.doi.org/10.1177/15579883221074789] [PMID: 35125015]
[29]
Novak JR, Peak T, Gast J, Arnell M. Associations between masculine norms and health-care utilization in highly religious, heterosexual men. Am J Men Health 2019; 13(3)
[http://dx.doi.org/10.1177/1557988319856739] [PMID: 31184245]
[30]
Haider A, Bengs S, Luu J, et al. Sex and gender in cardiovascular medicine: Presentation and outcomes of acute coronary syndrome. Eur Heart J 2020; 41(13): 1328-36.
[http://dx.doi.org/10.1093/eurheartj/ehz898] [PMID: 31876924]
[31]
Henry S, Bond R, Rosen S, Grines C, Mieres J. Challenges in cardiovascular risk prediction and stratification in women. Cardiovasc Innov Appl 2019; 3(4): 329.
[http://dx.doi.org/10.15212/CVIA.2017.0068]
[32]
Majidi M, Eslami V, Ghorbani P, Foroughi M. Are women more susceptible to ischemic heart disease compared to men? A literature overview. J Geriatr Cardiol 2021; 18(4): 289-96.
[http://dx.doi.org/10.11909/J.ISSN.1671-5411.2021.04.004] [PMID: 33995508]
[33]
Taqueti VR. Sex differences in the coronary system. Adv Exp Med Biol 2018; 1065: 257-78.
[http://dx.doi.org/10.1007/978-3-319-77932-4_17] [PMID: 30051390]
[34]
Eastwood JA. Gender differences in coronary artery disease. J Cardiovas Nurs 2005; 20(5): 340-51.
[http://dx.doi.org/10.1097/00005082-200509000-00008]
[35]
Wenger N. Clinical characteristics of coronary heart disease in women: Emphasis on gender differences. Cardiovasc Res 2002; 53(3): 558-67.
[http://dx.doi.org/10.1016/S0008-6363(01)00511-9] [PMID: 11861026]
[36]
Centers for Disease Control and Prevention and National Center for Chronic Disease Prevention and Health Promotion. Behavioral Risk Factor Surveillance System (BRFSS): BRFSS prevalence & trends data. Available from: https://www.cdc.gov/brfss/brfssprevalence/ (Accessed on: October 1, 2023).
[37]
Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update: A report from the American heart association. Circulation 2019; 139(10): e56-e528.
[http://dx.doi.org/10.1161/CIR.0000000000000659] [PMID: 30700139]
[38]
Tobacco use in Arkansas 2021.. Truth Initiative. Available from: https://truthinitiative.org/research-resources/smoking-region/tobacco-use-arkansas-2021
[39]
U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention (US) 2014.
[40]
Cornelius ME, Loretan CG, Wang TW, Jamal A, Homa DM. Tobacco product use among adults — United States, 2020. MMWR Morb Mortal Wkly Rep 2022; 71(11): 397-405.
[http://dx.doi.org/10.15585/mmwr.mm7111a1] [PMID: 35298455]
[41]
Jones DW, Sempos CT, Thom TJ, et al. Rising levels of cardiovascular mortality in Mississippi, 1979-1995. Am J Med Sci 2000; 319(3): 131-7.
[http://dx.doi.org/10.1097/00000441-200003000-00001] [PMID: 10746822]
[42]
Mendy VL, Rowell-Cunsolo T, Bellerose M, Vargas R, Enkhmaa B, Zhang L. Cardiovascular disease mortality in Mississippi, 2000–2018. Prev Chronic Dis 2022; 19: 210385.
[http://dx.doi.org/10.5888/pcd19.210385] [PMID: 35201975]
[43]
Healthcare System Performance. Center for mississippi health policy. 2022. Available from: https://mshealthpolicy.com/healthcare-system-performance/ (Accessed on: April 23, 2023).

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy